Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

NCT03229200

Conditions
Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center Burbank, California, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
View all 98 locations
View Trial Details
Active, Not Recruiting

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

NCT05371093

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Stanford Health Care Stanford, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Kansas Hospital Westwood, Kansas, United States
View all 52 locations
View Trial Details

Related conditions